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UNLABELLED: Aim & methods: The aim of the present work was to encapsulate
paclitaxel (Ptx) in various lipid nanocapsules (LNCs) formulations and then to
compare their pharmacokinetics and efficacy on a subcutaneous isograft model in
rats.
RESULTS: Three different Ptx formulations were obtained. Drug payloads ranged
from 1.32 to 3.62 mg Ptx/g of formulation. After oral administration the area under
concentration-time curve was higher (p < 0.05) if Ptx was encapsulated, (1,2
Distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(PEG)] (DSPE-PEG-NH2))
LNCs displaying the highest area under concentration-time curve (p < 0.05).
Efficacy was better than control for standard LNCs after oral administration (p <
0.05) and for (DSPE-PEG-NH2) LNCs after intravenous administration. Despite
good absorption, (DSPE-PEG-NH2) LNCs failed to remain efficient after oral route.
CONCLUSION: This study highlights the importance of efficacy studies paired to
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